Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ACULAR
- Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma
- S.L. Spray Solution® and Difflam® and Acular®Spray for the Prevention of Postoperative Sore Throat
- Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel
- Femoral Nerve Block Compared to Exparel in Total Knee Replacement
- Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular
- Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification
- Protein Profile of Immunoregulatory Factors in Diabetic Cataract
- Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis
- Ketorolac Plus Tobramycin/Dexamethasone Versus Tobramycin/Dexamethasone After Uneventful Phacoemulsification Surgery
- Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery
- Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy
- Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
- Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
- Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
- Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
- Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
- Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
- Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
- Ketorolac vs. Steroid in the Prevention of CME
- Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK
- Effect of Prophylactic Ketorolac on CME After Cataract Surgery
- Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
- Nevanac 3-Month Safety Study With QID Dosing
Clinical trials list
click for details